Antigenic drift of influenza A (H3N2) virus in a persistently infected immunocompromised host is similar to that occurring in the community

Clinical Infectious Diseases

Volumn 29, Issue 2, 1999, Pages 456-458

  McMinn, Peter ^a,b   Carrello, Angela ^a,b   Cole, Catherine ^a,b   Baker, David ^a,b   Hampson, Alan ^a,b  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ANTIGENIC VARIATION; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; FEMALE; GENETIC ANALYSIS; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; INFANT; INFLUENZA; INFLUENZA VIRUS A; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEROCONVERSION; VIRUS ISOLATION; VIRUS SHEDDING;

EID: 0032787912     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520243     Document Type: Article

References (5)

1. 1. Ryan-Poirier K. Influenza virus infection in children. Adv Pediatr Infect Dis 1995;10:125-56.
2. 2. Yap KL, Ada GL, McKenzie IFC. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 1978;273: 238-9.
3. 3. McMichael AJ, Gotch FM, Noble GR, Beare PAS. Cytotoxic T cell immunity to influenza. N Engl J Med 1983;309:13-7.
4. 4. Harrison C, Jenski L, Cox NJ, et al. Onset of cell-mediated immune function after bone marrow transplantation coincides with cessation of chronic shedding of influenza virus. In: Kendal AP, Patriarca PA, eds. Options for the control of influenza. New York: Alan R. Liss, 1986: 487-96.
5. 5. Rocha E, Cox NJ, Black RA, Harmon MW, Harrison CJ, Kendal AP. Antigenic and genetic variation in influenza A (HINI) virus isolates recovered from a persistently infected immunodeficient child. J Virol 1991;65:2340-50.